139 related articles for article (PubMed ID: 11279146)
1. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells.
Ghosh N; Gyory I; Wright G; Wood J; Wright KL
J Biol Chem; 2001 May; 276(18):15264-8. PubMed ID: 11279146
[TBL] [Abstract][Full Text] [Related]
2. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
3. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
5. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
Györy I; Fejér G; Ghosh N; Seto E; Wright KL
J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma.
Cycon KA; Mulvaney K; Rimsza LM; Persky D; Murphy SP
Immunology; 2013 Oct; 140(2):259-72. PubMed ID: 23789844
[TBL] [Abstract][Full Text] [Related]
7. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
Kong X; Fang M; Li P; Fang F; Xu Y
J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
[TBL] [Abstract][Full Text] [Related]
8. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
Ren B; Chee KJ; Kim TH; Maniatis T
Genes Dev; 1999 Jan; 13(1):125-37. PubMed ID: 9887105
[TBL] [Abstract][Full Text] [Related]
9. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
10. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
[TBL] [Abstract][Full Text] [Related]
14. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
[TBL] [Abstract][Full Text] [Related]
15. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
16. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.
Gyory I; Wu J; Fejér G; Seto E; Wright KL
Nat Immunol; 2004 Mar; 5(3):299-308. PubMed ID: 14985713
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.
Yu J; Angelin-Duclos C; Greenwood J; Liao J; Calame K
Mol Cell Biol; 2000 Apr; 20(7):2592-603. PubMed ID: 10713181
[TBL] [Abstract][Full Text] [Related]
18. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy.
Bontron S; Ucla C; Mach B; Steimle V
Mol Cell Biol; 1997 Aug; 17(8):4249-58. PubMed ID: 9234682
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
20. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.
Silacci P; Mottet A; Steimle V; Reith W; Mach B
J Exp Med; 1994 Oct; 180(4):1329-36. PubMed ID: 7931066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
